US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist

8.280
-0.010-0.12%

Close Feb 25 16:00 ET

8.250
-0.030-0.36%

Post 20:01 ET

1.73BMarket Cap-19.26P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioCryst Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 24, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	130.05M	131.53M	+1.49M
Beat Est.	+39.23%	+40.83%	+1.14%
EPS	-0.05	-0.13	-0.08
Miss Est.	+82.38%	+58.06%	-138.10%

Analyst Rating

Strong Buy

Feb 25, 2025

BioCryst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 138.532M	--
--	2025/Q1	-- / 126.461M	--
Feb 24, 2025	2024/Q4	131.534M / 130.047M	--
Nov 4, 2024	2024/Q3	117.085M / 112.666M	--
Aug 5, 2024	2024/Q2	109.332M / 98.324M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 138.532M--

--2025/Q1-- / 126.461M--

Feb 24, 20252024/Q4131.534M / 130.047M--

Nov 4, 20242024/Q3117.085M / 112.666M--

Aug 5, 20242024/Q2109.332M / 98.324M--

Unlock Free Earnings Estimates

Open Account

BioCryst Pharmaceuticals Earnings Reports

BioCryst Pharmaceuticals | 10-K: FY2024 Annual Report

16:09 ET

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones

Feb 24 07:07 ET

BioCryst Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 5, 2024 17:21 ET

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 4, 2024 07:09 ET